Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | PDK2 | Q15119 | 10/20 | 0.35 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.35 |
| ▸ | TSPO | P30536 | 1/20 | 0.33 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | RXRA | P19793 | 1/20 | 0.30 |
| ▸ | RXRB | P28702 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29353483 | 0.97 | KDM4E (0.38) | KDM4EATML3MBTL1PDK2HDAC4 | |
| SCHEMBL13828831 | 0.97 | KDM4E (0.38) | KDM4EATML3MBTL1PDK2HDAC4 | |
| SCHEMBL528038 | 0.97 | KDM4E (0.38) | KDM4EATML3MBTL1PDK2HDAC4 | |
| SCHEMBL23423497 | 0.97 | KDM4E (0.38) | KDM4EATML3MBTL1PDK2HDAC4 | |
| SCHEMBL29638729 | 0.97 | KDM4E (0.38) | KDM4EATML3MBTL1PDK2HDAC4 | |
| SCHEMBL23423862 | 0.97 | KDM4E (0.38) | KDM4EATML3MBTL1PDK2HDAC4 | |
| SCHEMBL19061254 | 0.93 | KDM4E (0.45) | KDM4EATML3MBTL1PDK2HDAC4 | |
| SCHEMBL23423601 | 0.93 | KDM4E (0.38) | KDM4EATML3MBTL1PDK2HDAC4 | |
| SCHEMBL23423864 | 0.93 | KDM4E (0.38) | KDM4EATML3MBTL1PDK2HDAC4 | |
| SCHEMBL21446499 | 0.93 | KDM4E (0.38) | KDM4EATML3MBTL1PDK2HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11171292-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2021-11-09 | — | — | US | disclosed |
| US-20200373488-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED | SEMICONDUCTOR ENERGY LAB (JP) | 2020-11-26 | — | — | US | disclosed |
| US-20180083191-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED | SEMICONDUCTOR ENERGY LAB (JP) | 2018-03-22 | — | — | US | disclosed |
| US-9831440-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-11-28 | — | — | US | disclosed |
| US-20170018711-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED | SEMICONDUCTOR ENERGY LAB (JP) | 2017-01-19 | — | — | US | disclosed |
| US-9461248-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-10-04 | — | — | US | disclosed |
| US-20150005509-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED | SEMICONDUCTOR ENERGY LAB (JP) | 2015-01-01 | — | — | US | disclosed |
| US-8835018-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-09-16 | — | — | US | disclosed |
| US-8835018-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-09-16 | — | — | US | disclosed |
| US-20080268284-A1 | Anthrcene bonded to a carbazole through an aryl amine; emits blue light with high color purity; reduced power consumption | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-10-30 | — | — | US | disclosed |
| US-20080268284-A1 | Anthrcene bonded to a carbazole through an aryl amine; emits blue light with high color purity; reduced power consumption | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-10-30 | — | — | US | disclosed |
| EP-1985613-A2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-10-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080268284-A1 | Anthrcene bonded to a carbazole through an aryl amine; emits blue light with high color purity; reduced power consumption | CRY1, CRY2, CYBA | KDM4E 2102/4885ATM 634/4885L3MBTL1 3828/4885 |
| US-20170018711-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED | CYP1A1, CYP1A2, XPOT | KDM4E 2894/4885ATM 425/4885L3MBTL1 1845/4885 |
| US-20200373488-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED | CYP1A1, CYP1A2, XPOT | KDM4E 2894/4885ATM 425/4885L3MBTL1 1845/4885 |
| US-11171292-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | CYP1A1, CYP1A2, XPOT | KDM4E 2894/4885ATM 425/4885L3MBTL1 1845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.